Transitioning to telegenetics in the COVID-19 era: Patient satisfaction with remote genetic counseling in adult neurology.
COVID-19
genetic counseling
neurogenetics
telegenetics
telehealth
telemedicine
Journal
Journal of genetic counseling
ISSN: 1573-3599
Titre abrégé: J Genet Couns
Pays: United States
ID NLM: 9206865
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
revised:
17
06
2021
received:
12
01
2021
accepted:
20
06
2021
pubmed:
16
7
2021
medline:
29
9
2021
entrez:
15
7
2021
Statut:
ppublish
Résumé
The COVID-19 pandemic rapidly changed genetic counseling services across the United States. At the University of Pennsylvania (UPenn), a large academic hospital in an urban setting, nearly all genetic counseling (GC) visits for adult-onset disorders within the Department of Neurology were conducted via secure videoconferencing (telegenetics) or telephone between March and December 2020. Although telemedicine services have been steadily emerging, many clinical programs, including the neurogenetics program at UPenn, had not built infrastructure or widely utilized these services prior to the pandemic. Thus, little is known about patient attitudes toward receiving clinical GC services remotely. From May 18 to October 18, 2020, all individuals seen remotely for GC in adult neurology via telephone or telegenetics were surveyed about their satisfaction with telehealth GC (N = 142), with a response rate of 42% (N = 60/142). Telephone and telegenetics services were referred to as 'telehealth' in the surveys to capture patient perspectives on all remote GC services, though the majority (N = 49/60) of these visits were completed via telegenetics. Surveys included the modified telehealth usability questionnaire (MTUQ), genetic counseling satisfaction scale (GCSS), and novel questions about future telehealth use. Preliminary results suggest that patients were satisfied with receiving remote GC services in adult neurology, with most participants strongly agreeing to all items about satisfaction with telehealth. Just 2% of participants preferred only in-person visits in the future, but every participant was willing to consider using telehealth for future visits if their genetic counselor felt it was appropriate. Most participants preferred a hybrid model (73%), and some (25%) preferred only telehealth for future visits. Additionally, we found no differences in satisfaction with remote services based on visit type (initial vs. results disclosure) nor age. We conclude that remote GC is an acceptable method for the provision of services in adult neurology that is well-received by patients.
Identifiants
pubmed: 34265143
doi: 10.1002/jgc4.1470
pmc: PMC8427091
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
974-983Informations de copyright
© 2021 National Society of Genetic Counselors.
Références
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
J Genet Couns. 2018 Apr;27(2):320-322
pubmed: 29264692
J Genet Couns. 2021 Aug;30(4):974-983
pubmed: 34265143
Genet Med. 2011 Nov;13(11):933-41
pubmed: 21799430
J Genet Couns. 2014 Dec;23(6):903-9
pubmed: 24841456
J Genet Couns. 2012 Oct;21(5):645-51
pubmed: 22566244
J Genet Couns. 2021 Aug;30(4):984-988
pubmed: 33277765
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
JAMA Netw Open. 2020 Dec 1;3(12):e2031640
pubmed: 33372974
J Med Internet Res. 2016 Feb 01;18(2):e23
pubmed: 26831751
J Genet Couns. 2020 Aug;29(4):634-643
pubmed: 31749259
J Genet Couns. 2020 Dec;29(6):1126-1141
pubmed: 32314856
J Genet Couns. 2017 Oct;26(5):902-933
pubmed: 28255928
Genet Med. 2020 Mar;22(3):574-580
pubmed: 31680121
J Genet Couns. 2006 Jun;15(3):199-205
pubmed: 16779676
J Genet Couns. 2018 Apr;27(2):329-338
pubmed: 29362948
Patient Educ Couns. 2001 Apr;43(1):73-84
pubmed: 11311841
J Genet Couns. 2015 Dec;24(6):961-70
pubmed: 25833335
Clin Genet. 2019 Feb;95(2):293-301
pubmed: 30417332
Telemed J E Health. 2018 Feb;24(2):130-138
pubmed: 28737998
Telemed J E Health. 2021 Sep;27(9):1078-1084
pubmed: 33337290
J Genet Couns. 2014 Apr;23(2):221-8
pubmed: 24014153
Telemed J E Health. 2019 Jul;25(7):541-550
pubmed: 30136898
Am Soc Clin Oncol Educ Book. 2019 Jan;39:e34-e44
pubmed: 31099680
J Genet Couns. 2010 Oct;19(5):463-72
pubmed: 20411313
Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):624-7
pubmed: 20142257
JAMA Oncol. 2015 Dec;1(9):1251-60
pubmed: 26426480
J Natl Cancer Inst. 2018 Sep 1;110(9):985-993
pubmed: 29490071
Am J Med Genet C Semin Med Genet. 2021 Mar;187(1):28-36
pubmed: 33225573
Genet Med. 2005 Jan;7(1):1-2
pubmed: 15654221
Mov Disord. 2014 Jun;29(7):871-83
pubmed: 24838316
Alzheimers Dement (N Y). 2016 Oct 15;3(1):57-64
pubmed: 29067319
Int J Telerehabil. 2016 Jul 01;8(1):3-10
pubmed: 27563386
Health Aff (Millwood). 2018 Dec;37(12):1923-1930
pubmed: 30633670
J Genet Couns. 2016 Oct;25(5):1010-8
pubmed: 26762366
Genet Med. 2012 Sep;14(9):765-76
pubmed: 22498847
Clin Genet. 2011 Feb;79(2):125-31
pubmed: 21039431
J Genet Couns. 2007 Dec;16(6):713-28
pubmed: 17934802
Front Oncol. 2016 May 13;6:120
pubmed: 27242960
Neurol Clin Pract. 2016 Jun;6(3):241-251
pubmed: 27347441
Int J Med Inform. 2010 Nov;79(11):736-71
pubmed: 20884286